NCT04070573View on ClinicalTrials.gov

Low Doses of Aspirin in the Prevention of Preeclampsia

PHASE3CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

October 21, 2019

Primary Completion Date

March 4, 2024

Study Completion Date

January 23, 2025

Conditions
Preeclampsia
Interventions
DRUG

acetylsalicylic acid

High risk pregnant women will be treated with daily aspirin during pregnancy.

Trial Locations (2)

10065

New York Presbyterian - Weill Cornell, New York

11355

New York Presbyterian Queens, New York

All Listed Sponsors
lead

Weill Medical College of Cornell University

OTHER

NCT04070573 - Low Doses of Aspirin in the Prevention of Preeclampsia | Biotech Hunter | Biotech Hunter